Effects of L-lysine and its metabolites on pentylenetetrazol-induced seizures.
Lysine and its metabolic intermediates were studied for their effect on pentylenetetrazol (PTZ)-induced seizures in mice. L-Lysine at dosages above 2 mmol/kg given i.p. significantly increased seizure protection and seizure latency (the time required to develop seizures after PTZ injection) with a peak effect dose at 10 mmol/kg. A pretreatment time of 15 min was required to significantly prolong seizure latency with a peak effect time of 45 min. D-Lysine at 10 mmol/kg i.p. afforded some seizure protection and significantly prolonged seizure latency but has a peak effect time of 15 min. When administered intracerebroventricularly, both L-lysine and piperidine at 0.1 mmol/kg prolonged seizure latency significantly, and increased seizure protection slightly. L-Pipecolic acid at the same dose given through the same route, however, shortened seizure latency significantly. L-alpha-Aminoadipic acid, on the other hand, had no significant effect. Lysine metabolites that prolonged seizure latency also increased seizure protection and decreased seizure death, and one that shortened seizure latency had the opposite effect. The anticonvulsant activity of lysine and its metabolites was explained on the basis of their connection with the GABAergic transmission.
D015074:2-Aminoadipic Acid / Q000627:therapeutic use; D000818:Animals; D000927:Anticonvulsants; D008239:Lysine / Q000627:therapeutic use*; D008297:Male; D051379:Mice; D010433:Pentylenetetrazole / Q000037:antagonists & inhibitors*; D010875:Pipecolic Acids / Q000627:therapeutic use; D010880:Piperidines / Q000627:therapeutic use; D012640:Seizures / Q000139:chemically induced / Q000188:drug therapy*; D009435:Synaptic Transmission; D005680:gamma-Aminobutyric Acid / Q000502:physiology
D000927:Anticonvulsants; D010875:Pipecolic Acids; D010880:Piperidines; D015074:2-Aminoadipic Acid; D005680:gamma-Aminobutyric Acid; C032727:piperidine; C031345:pipecolic acid; D008239:Lysine; D010433:Pentylenetetrazole